Zhuhai Sailong Pharmaceutical Co Ltd
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pan… Read more
Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Total Liabilities
Latest total liabilities as of September 2025: CN¥337.07 Million CNY
Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has total liabilities worth CN¥337.07 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhuhai Sailong Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2024)
This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Impact Develop
RO:IMP
|
Romania | RON308.18 Million |
|
K.P. Energy Limited
NSE:KPEL
|
India | ₹8.92 Billion |
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
USA | $1.82 Billion |
|
Orthocell Ltd
AU:OCC
|
Australia | AU$20.67 Million |
|
Syscom Computer Engineering Co
TW:2453
|
Taiwan | NT$2.76 Billion |
|
MicroPort CardioFlow Medtech Corporation
PINK:MROPF
|
USA | $450.55 Million |
|
X-Legend Entertainment Co Ltd
TW:4994
|
Taiwan | NT$297.82 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Zhuhai Sailong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhuhai Sailong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2024)
The table below shows the annual total liabilities of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥308.95 Million | +11.15% |
| 2023-12-31 | CN¥277.96 Million | -13.58% |
| 2022-12-31 | CN¥321.64 Million | +0.79% |
| 2021-12-31 | CN¥319.12 Million | +40.61% |
| 2020-12-31 | CN¥226.96 Million | +28.26% |
| 2019-12-31 | CN¥176.95 Million | +91.71% |
| 2018-12-31 | CN¥92.30 Million | -4.35% |
| 2017-12-31 | CN¥96.50 Million | +88.43% |
| 2016-12-31 | CN¥51.21 Million | -0.63% |
| 2015-12-31 | CN¥51.53 Million | +5.32% |
| 2014-12-31 | CN¥48.93 Million | -34.27% |
| 2013-12-31 | CN¥74.44 Million | -- |